SEOM-GEM clinical guidelines for cutaneous melanoma (2023)


Por: Marquez-Rodas, Ivan, Couselo, Eva Munoz, Moreno, Juan F. Rodriguez, Fernandez, Ana Ma Arance, Guerrero, Miguel Angel Berciano, Balea, Begona Campos, Merino, Luis de la Cruz, Arranz, Enrique Espinosa, Castano, Almudena Garcia, Jaime, Alfonso Berrocal

Publicada: 1 nov 2024 Ahead of Print: 1 may 2024
Resumen:
Cutaneous melanoma incidence is rising. Early diagnosis and treatment administration are key for increasing the chances of survival. For patients with locoregional advanced melanoma that can be treated with complete resection, adjuvant-and more recently neoadjuvant-with targeted therapy-BRAF and MEK inhibitors-and immunotherapy-anti-PD-1-based therapies-offer opportunities to reduce the risk of relapse and distant metastases. For patients with advanced disease not amenable to radical treatment, these treatments offer an unprecedented increase in overall survival. A group of medical oncologists from the Spanish Society of Medical Oncology (SEOM) and Spanish Multidisciplinary Melanoma Group (GEM) has designed these guidelines, based on a thorough review of the best evidence available. The following guidelines try to cover all the aspects from the diagnosis-clinical, pathological, and molecular-staging, risk stratification, adjuvant therapy, advanced disease therapy, and survivor follow-up, including special situations, such as brain metastases, refractory disease, and treatment sequencing. We aim help clinicians in the decision-making process.

Filiaciones:
Hosp Gen Univ Gregorio Maranon, Madrid, Spain
Hosp Valle De Hebron, Barcelona, Spain
Vall dHebron Inst Oncol VHIO, Barcelona, Spain
HM Hosp, Inst Invest Sanitaria, Madrid, Spain
Hosp Clin Barcelona, Barcelona, Spain
Hosp Univ Reg & Virgen Victoria HURyVV, Unidad Interctr Oncol, Malaga,
Spain
Hosp Univ Lucus Augusti, Lugo, Spain
Univ Hosp Virgen Macarena, Biomed Inst Seville IBIS, Clin Oncol Dept,
Canc Immunotherapy,CSIC, Seville, Spain
Univ Seville, Sch Med, Seville, Spain
Hosp Univ La Paz, CIBERONC, Madrid, Spain
Hosp Univ Marques Valdecilla, Santander, Spain
Consorcio Hosp Gen Univ, Valencia, Spain
ISSN: 1699048X





CLINICAL & TRANSLATIONAL ONCOLOGY
Editorial
SPRINGER-VERLAG ITALIA SRL, VIA DECEMBRIO, 28, MILAN, 20137, ITALY, Italia
Tipo de documento: Article
Volumen: 26 Número: 11
Páginas: 2841-2855
WOS Id: 001223466100002
ID de PubMed: 38748192

MÉTRICAS